IMMU - all time are in central time (i forgot to mention - please read the link below for the details) IMMU reminder - 3 data presentation(s) Thursday, December 8, 2016 Directing NK cells to Trop-2-expressing breast and other cancers, with chimeric antigen receptors (Chang, et al.) Poster Session: Tumor Cell and Molecular Biology: Immunology and Preclinical Immunotherapy Program Number: P2-04-17 Abstract # 246 7:30 a.m. - 9:00 a.m. Hall 1 Friday, December 9, 2016 Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate (ADC) for the treatment of relapsed/refractory, metastatic triple-negative breast cancer (mTNBC): Updated results (Bardia, et al.) Poster Session: Treatment: Advanced Therapy - Targeted Program Number: P4-22-15 Abstract # 339, 7:30 a.m. - 9:00 a.m. Hall 1 Saturday, December 10, 2016 Enhanced efficacy of redirected T-cell therapy of TNBC with a Trop-2/CD3 bispecific antibody in combination with a checkpoint inhibitor (Rossi, et al.) Poster Session: Treatment: Antibody-Based Regimens Program Number: P6-14-01 Abstract # 510, 7:30 a.m. - 9:00 a.m. Hall 1 http://finance.yahoo.com/news/immunomedics-clinical-sacituzumab-govitecan-immu-203000762.html